ARTICLE | Company News
Alpha 1 Biomedicals, Cel-Sci deal
May 15, 1995 7:00 AM UTC
The companies' Viral Technologies Inc. joint venture reacquired from Nippon Zeon the Far Eastern marketing rights to HGP-30, a candidate HIV vaccine/treatment. Viral Technologies said Nippon Zeon's me...